SubsidieMeestersPrecision tissue biobanking made easy
The project aims to develop and validate an automated tissue harvesting system, ARTS, to enhance biobanking efficiency, quality, and sustainability for improved disease research and diagnostics.
Projectdetails
Introduction
Large scale biobanks are essential to meet the world-wide demand for high quality tissues to understand the development and progression of disease, or discover and validate novel biomarkers. Current biobanking protocols for harvesting and processing tissue are manual and therefore rely on experienced and costly on-site personnel.
Vision for Improvement
Imagine the possibilities of scientific discoveries in personalized diagnostics, prognostics, and treatment if high-quality tissues could be made available from several hospitals using streamlined, harmonized, and automated biobanking protocols. These protocols would also allow for maximal utilization of this precious material.
Proposed Solution
In this PoC, we propose a shift from a human-centered to a semi- or fully automated tissue harvesting and processing protocol. Specifically, we propose to develop further, test, and validate (from TRL4 to TRL7) an Augmented Reality enhanced and automated Tissue Sampler (ARTS).
Features of ARTS
The ARTS technology is:
- Cost-effective
- Simple to operate
- Allows for maximal tissue utilization
The ARTS prototype was developed within my ongoing ERC StG and already enables sub-samples to be selected from tissue based on invisible features such as diseased and non-diseased cells, addressing one of the general challenges of biobanking today.
Process Monitoring and Quality Assurance
In this PoC, we will include comprehensive process monitoring and sample tracking features such as:
- Position
- Temperature
- Processing time
These features will allow automated sub-sampling while ensuring operator quality assurance with minimal hands-on time.
User Interface and Industry Readiness
We will also incorporate a tested user-friendly interface ready for industry and a potential spin-off company.
Benefits of ARTS
ARTS will allow biobanks to serve customers with specific and high-quality targeted sub-samples, which will enhance the value of the material through:
- Increased reproducibility
- Faster processing
- More efficient utilization
In addition, ARTS will relieve financial burden and achieve more long-term sustainability for biobanks, which typically depend on public funding.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 150.000 |
| Totale projectbegroting | € 150.000 |
Tijdlijn
| Startdatum | 1-1-2023 |
| Einddatum | 30-6-2024 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNUpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical propertiesThe project aims to develop the TissMec system for automated 3D human tissue creation and screening to expedite drug candidate evaluation and improve the drug development process. | ERC Proof of... | € 150.000 | 2024 | Details |
High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug DiscoveryThe project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows. | ERC Proof of... | € 150.000 | 2025 | Details |
Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues. | ERC Consolid... | € 1.965.525 | 2024 | Details |
Integrated AI-Driven Systems For Kidney Transplant Precision Medicine (AI-Care)The ERC AI-Care project aims to enhance long-term kidney transplant outcomes through personalized, non-invasive monitoring and advanced diagnostic technologies for rejection risk assessment. | ERC Consolid... | € 1.997.935 | 2024 | Details |
Prostate Diagnosis using Optical Coherence TomographyThe PROCT project aims to enhance prostate cancer diagnosis by developing a semiautonomous robotic system using Optical Coherence Tomography for accurate, in vivo lesion analysis without biopsies. | ERC Proof of... | € 150.000 | 2022 | Details |
3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties
The project aims to develop the TissMec system for automated 3D human tissue creation and screening to expedite drug candidate evaluation and improve the drug development process.
High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug Discovery
The project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows.
Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.
The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues.
Integrated AI-Driven Systems For Kidney Transplant Precision Medicine (AI-Care)
The ERC AI-Care project aims to enhance long-term kidney transplant outcomes through personalized, non-invasive monitoring and advanced diagnostic technologies for rejection risk assessment.
Prostate Diagnosis using Optical Coherence Tomography
The PROCT project aims to enhance prostate cancer diagnosis by developing a semiautonomous robotic system using Optical Coherence Tomography for accurate, in vivo lesion analysis without biopsies.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
AI and Robotics for Prostate BiopsyThe ROBIOPSY project aims to develop a robotic prostate biopsy prototype for clinical trials, enhancing diagnostic accuracy and addressing health economics for improved cancer treatment. | EIC Transition | € 2.499.141 | 2023 | Details |
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgansTHOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants. | EIC Pathfinder | € 3.994.150 | 2023 | Details |
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to LabBiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening. | EIC Transition | € 2.500.000 | 2022 | Details |
Een schaalbaar en patiëntvriendelijk alternatief voor veneuze prikmethode voor bloedafnameHet project ontwikkelt een bloedsampler om laagdrempelig bloedafname voor preventieve zorg te faciliteren, gericht op het verbeteren van doelmatigheid en het verlichten van personeelstekorten. | Mkb-innovati... | € 20.000 | 2023 | Details |
Chemometric histopathology via coherent Raman imaging for precision medicineThe CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification. | EIC Transition | € 2.441.979 | 2022 | Details |
AI and Robotics for Prostate Biopsy
The ROBIOPSY project aims to develop a robotic prostate biopsy prototype for clinical trials, enhancing diagnostic accuracy and addressing health economics for improved cancer treatment.
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans
THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to Lab
BiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening.
Een schaalbaar en patiëntvriendelijk alternatief voor veneuze prikmethode voor bloedafname
Het project ontwikkelt een bloedsampler om laagdrempelig bloedafname voor preventieve zorg te faciliteren, gericht op het verbeteren van doelmatigheid en het verlichten van personeelstekorten.
Chemometric histopathology via coherent Raman imaging for precision medicine
The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.